Drug
Rusfertide
Rusfertide is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting1
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
active_not_recruiting133%
not_yet_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07648030Phase 2
A Study of Rusfertide in Japanese Adults With Polycythemia Vera
NCT07765602Phase 2
A Study of Rusfertide in Adults With Polycythemia Vera in China
NCT05210790Phase 3
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3